The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme.

IF 9.6 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL EClinicalMedicine Pub Date : 2024-07-16 eCollection Date: 2024-08-01 DOI:10.1016/j.eclinm.2024.102597
Chen Wang, Weiran Qi, Ting Yang, Lirui Jiao, Qiushi Chen, Ke Huang, Fengyun Yu, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen
{"title":"The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme.","authors":"Chen Wang, Weiran Qi, Ting Yang, Lirui Jiao, Qiushi Chen, Ke Huang, Fengyun Yu, Pascal Geldsetzer, Till Bärnighausen, Simiao Chen","doi":"10.1016/j.eclinm.2024.102597","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Understanding the chronic obstructive pulmonary disease (COPD) care cascade is crucial for identifying where and when to intervene to improve COPD outcomes. We aimed to determine the proportion of patients with COPD seeking care in China's health system who are lost at each stage of the COPD care cascade and how the patterns of loss vary across geographical regions and population groups.</p><p><strong>Methods: </strong>From November 3, 2018, to April 22, 2021, we used individual-level patient data from the national Chinese 'Happy Breathing' Programme, which aims to identify patients with COPD and provide appropriate care. COPD was defined as a post-bronchodilator ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) <0.70. We calculated the proportions of individuals who, at enrolment into the 'Happy Breathing' Programme, (i) had ever undergone a pulmonary function test, (ii) had been diagnosed with COPD in the past, (iii) were currently on treatment for COPD, and (iv) had achieved control of their COPD. We examined the association between reaching each stage of the care cascade and individual patient characteristics as well as regional-level economic development and available resources in the health system using multilevel regression.</p><p><strong>Findings: </strong>Among the 29,201 patients with COPD in the 'Happy Breathing' Programme, 41.0% (95% confidence interval [CI]: 40.4-41.6%) had ever been tested for COPD, 17.6% (95% CI: 17.1-18.0%) had previously been diagnosed with COPD, 8.5% (95% CI: 8.2-8.8%) were currently on treatment for COPD, 4.6% (95% CI: 4.3-4.8%) of patients had mild or no exacerbations in the prior year, and 3.9% (95% CI: 3.7-4.2%) of patients had suffered no exacerbations in the prior year. On average, patients living in the cities of Beijing, Wuhan, and Yinchuan had progressed further along the COPD care cascade than patients living in Daqing and Luoyang. Using multilevel regression, we found that young age, rural residence, and low regional per-capita GDP were significantly associated with larger losses at each stage of the COPD care cascade.</p><p><strong>Interpretation: </strong>Substantial proportions of patients with COPD are lost at each stage of the COPD care cascade in the Chinese health system. The largest losses occur during the initial stages of the cascade, when diagnosis first occurs. New policies and interventions are required to boost COPD care, especially screening and diagnosis, in the Chinese health system to reduce this large disease burden.</p><p><strong>Funding: </strong>This work was supported by Major Programme of National Natural Science Foundation of China (82090011), CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-049), and Horizon Europe (HORIZON-MSCA-2021-SE-01; project number 101086139-PoPMeD-SuSDeV). TB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt professorship award.</p>","PeriodicalId":11393,"journal":{"name":"EClinicalMedicine","volume":null,"pages":null},"PeriodicalIF":9.6000,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11305216/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EClinicalMedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.eclinm.2024.102597","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Understanding the chronic obstructive pulmonary disease (COPD) care cascade is crucial for identifying where and when to intervene to improve COPD outcomes. We aimed to determine the proportion of patients with COPD seeking care in China's health system who are lost at each stage of the COPD care cascade and how the patterns of loss vary across geographical regions and population groups.

Methods: From November 3, 2018, to April 22, 2021, we used individual-level patient data from the national Chinese 'Happy Breathing' Programme, which aims to identify patients with COPD and provide appropriate care. COPD was defined as a post-bronchodilator ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC) <0.70. We calculated the proportions of individuals who, at enrolment into the 'Happy Breathing' Programme, (i) had ever undergone a pulmonary function test, (ii) had been diagnosed with COPD in the past, (iii) were currently on treatment for COPD, and (iv) had achieved control of their COPD. We examined the association between reaching each stage of the care cascade and individual patient characteristics as well as regional-level economic development and available resources in the health system using multilevel regression.

Findings: Among the 29,201 patients with COPD in the 'Happy Breathing' Programme, 41.0% (95% confidence interval [CI]: 40.4-41.6%) had ever been tested for COPD, 17.6% (95% CI: 17.1-18.0%) had previously been diagnosed with COPD, 8.5% (95% CI: 8.2-8.8%) were currently on treatment for COPD, 4.6% (95% CI: 4.3-4.8%) of patients had mild or no exacerbations in the prior year, and 3.9% (95% CI: 3.7-4.2%) of patients had suffered no exacerbations in the prior year. On average, patients living in the cities of Beijing, Wuhan, and Yinchuan had progressed further along the COPD care cascade than patients living in Daqing and Luoyang. Using multilevel regression, we found that young age, rural residence, and low regional per-capita GDP were significantly associated with larger losses at each stage of the COPD care cascade.

Interpretation: Substantial proportions of patients with COPD are lost at each stage of the COPD care cascade in the Chinese health system. The largest losses occur during the initial stages of the cascade, when diagnosis first occurs. New policies and interventions are required to boost COPD care, especially screening and diagnosis, in the Chinese health system to reduce this large disease burden.

Funding: This work was supported by Major Programme of National Natural Science Foundation of China (82090011), CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1-049), and Horizon Europe (HORIZON-MSCA-2021-SE-01; project number 101086139-PoPMeD-SuSDeV). TB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt professorship award.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国慢性阻塞性肺病的护理级联:国家 "快乐呼吸 "项目入选时个人层面数据的横断面研究。
背景:了解慢性阻塞性肺病(COPD)的治疗过程对于确定何时何地进行干预以改善慢性阻塞性肺病的治疗效果至关重要。我们旨在确定在中国卫生系统中寻求治疗的慢性阻塞性肺疾病患者在慢性阻塞性肺疾病治疗级联的每个阶段流失的比例,以及不同地理区域和人群的流失模式有何差异:从 2018 年 11 月 3 日至 2021 年 4 月 22 日,我们使用了来自中国 "快乐呼吸 "全国项目的个人层面患者数据,该项目旨在识别慢性阻塞性肺病患者并提供适当的护理。慢性阻塞性肺病的定义是支气管扩张剂后 1 秒用力呼气容积与用力肺活量的比值(FEV1/FVC)结果:在参加 "快乐呼吸 "计划的 29 201 名慢性阻塞性肺病患者中,41.0%(95% 置信区间 [CI]:40.4-41.6%)曾接受过慢性阻塞性肺病检测,17.6%(95% 置信区间:17.1-18.0%)曾被诊断患有慢性阻塞性肺病,8.5%(95% CI:8.2%-8.8%)的患者目前正在接受慢性阻塞性肺病治疗,4.6%(95% CI:4.3%-4.8%)的患者上一年病情轻微或没有加重,3.9%(95% CI:3.7%-4.2%)的患者上一年病情没有加重。平均而言,居住在北京、武汉和银川市的患者比居住在大庆和洛阳的患者在慢性阻塞性肺疾病护理级联方面取得了更大的进展。通过多层次回归,我们发现年轻、居住在农村和地区人均 GDP 低与慢性阻塞性肺病护理级联各阶段的较大损失显著相关:在中国医疗系统中,慢性阻塞性肺疾病患者在慢性阻塞性肺疾病治疗级联的每个阶段都有相当大比例的流失。最大的损失发生在级联的初始阶段,即首次诊断时。中国卫生系统需要新的政策和干预措施来促进慢性阻塞性肺病的治疗,尤其是筛查和诊断,以减轻这一巨大的疾病负担:本研究得到了国家自然科学基金重大项目(82090011)、中国医学科学院医学科学创新基金(CIFMS)(2021-I2M-1-049)和欧洲地平线(HORIZON-MSCA-2021-SE-01;项目编号101086139-PoPMeD-SuSDeV)的资助。TB 由亚历山大-冯-洪堡基金会通过亚历山大-冯-洪堡教授奖提供支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
EClinicalMedicine
EClinicalMedicine Medicine-Medicine (all)
CiteScore
18.90
自引率
1.30%
发文量
506
审稿时长
22 days
期刊介绍: eClinicalMedicine is a gold open-access clinical journal designed to support frontline health professionals in addressing the complex and rapid health transitions affecting societies globally. The journal aims to assist practitioners in overcoming healthcare challenges across diverse communities, spanning diagnosis, treatment, prevention, and health promotion. Integrating disciplines from various specialties and life stages, it seeks to enhance health systems as fundamental institutions within societies. With a forward-thinking approach, eClinicalMedicine aims to redefine the future of healthcare.
期刊最新文献
Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis. CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial. Diagnostic performance of deep learning for infectious keratitis: a systematic review and meta-analysis. Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data. The global burden of enteric fever, 2017-2021: a systematic analysis from the global burden of disease study 2021.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1